This study is being done to learn more about the safety and effectiveness of VX-864 in participants with Alpha-1 Antitrypsin Deficiency (AATD). AATD is a rare genetic condition that can cause Chronic Obstructive Pulmonary Disease (COPD).
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Brad Drummond
Medicine-Pulmonary
Clinical or Medical
Interventional
Genetics and Genetic Disorders
Lungs and Breathing
22-2687
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
